Stocktoria

Viking Therapeutics, Inc. VKTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-04-29 · LEI

Viking Therapeutics, Inc. statistics & valuation

Market cap$3.4B
P / B5.4×
Return on equity-56.3%
Return on capital-61.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-183.20% -152.80% -7.40% -9.30% -16.20% -27.20% -47.40% -24.70% -12.50% -56.30% 2016201720182019202020212022202320242025
Shares outstanding
20.8M 35.8M 71.7M 72.4M 73.2M 78.2M 78.3M 100.1M 111.6M 114.8M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-101.30% -93.00% -7.30% -9.10% -15.40% -26.10% -40.90% -23.30% -12.10% -50.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.71 -$0.90 -$0.91 -$1.01 -$3.19 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-50.2%-12.1%-23.3%-40.9%-26.1%-15.4%-9.1%-7.3%-93.0%-101.3%
Return on equity-56.3%-12.5%-24.7%-47.4%-27.2%-16.2%-9.3%-7.4%-152.8%-183.2%
Current ratio9.3333.0919.197.6123.9821.1241.8366.402.522.16

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.